Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery.

Autor Kinzig, M, Sörgel, F, Brismar, B, Nord, C E
Vydáno 1992

Influence of changes in pancreatic tissue morphology and capillary blood flow on antibiotic tissue concentrations in the pancreas during the progression of acute pancreatitis.

Autor Foitzik, T, Hotz, H G, Kinzig, M, Sörgel, F, Buhr, H J
Vydáno 1997

Pharmacokinetics of fleroxacin after multiple oral dosing in patients receiving regular hemodialysis.

Autor Uehlinger, D E, Schaedeli, F, Kinzig, M, Sörgel, F, Frey, F J
Vydáno 1996

Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin.

Autor Nau, R, Kinzig, M, Dreyhaupt, T, Kolenda, H, Sörgel, F, Prange, H W
Vydáno 1994

New Semiphysiological Absorption Model To Assess the Pharmacodynamic Profile of Cefuroxime Axetil Using Nonparametric and Parametric Population Pharmacokinetics

Autor Bulitta, J. B., Landersdorfer, C. B., Kinzig, M., Holzgrabe, U., Sorgel, F.
Vydáno 2009

Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia

Autor Lodise, T. P., Sorgel, F., Melnick, D., Mason, B., Kinzig, M., Drusano, G. L.
Vydáno 2011

Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.

Autor Van der Auwera, P, Duchateau, V, Lambert, C, Husson, M, Kinzig, M, Sörgel, F
Vydáno 1993

Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues.

Autor Incavo, S J, Ronchetti, P J, Choi, J H, Wu, H, Kinzig, M, Sörgel, F
Vydáno 1994

Comparable Population Pharmacokinetics and Pharmacodynamic Breakpoints of Cefpirome in Cystic Fibrosis Patients and Healthy Volunteers

Autor Bulitta, J. B., Kinzig, M., Landersdorfer, C. B., Holzgrabe, U., Stephan, U., Sörgel, F.
Vydáno 2011

Blood, Tissue, and Intracellular Concentrations of Erythromycin and Its Metabolite Anhydroerythromycin during and after Therapy

Autor Krasniqi, S., Matzneller, P., Kinzig, M., Sörgel, F., Hüttner, S., Lackner, E., Müller, M., Zeitlinger, M.
Vydáno 2012

Blood, Tissue, and Intracellular Concentrations of Azithromycin during and after End of Therapy

Autor Matzneller, P., Krasniqi, S., Kinzig, M., Sörgel, F., Hüttner, S., Lackner, E., Müller, M., Zeitlinger, M.
Vydáno 2013

Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.

Autor Nau, R, Prange, H W, Kinzig, M, Frank, A, Dressel, A, Scholz, P, Kolenda, H, Sörgel, F
Vydáno 1996

Population Pharmacokinetic Comparison and Pharmacodynamic Breakpoints of Ceftazidime in Cystic Fibrosis Patients and Healthy Volunteers

Autor Bulitta, J. B., Landersdorfer, C. B., Hüttner, S. J., Drusano, G. L., Kinzig, M., Holzgrabe, U., Stephan, U., Sörgel, F.
Vydáno 2010

Impact of Spore Biology on the Rate of Kill and Suppression of Resistance in Bacillus anthracis

Autor Drusano, G. L., Okusanya, O. O., Okusanya, A. O., van Scoy, B., Brown, D. L., Fregeau, C., Kulawy, R., Kinzig, M., Sörgel, F., Heine, H. S., Louie, A.
Vydáno 2009

Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib‐Treated Cancer

Autor Diekstra, MH, Fritsch, A, Kanefendt, F, Swen, JJ, Moes, DJAR, Sörgel, F, Kinzig, M, Stelzer, C, Schindele, D, Gauler, T, Hauser, S, Houtsma, D, Roessler, M, Moritz, B, Mross, K, Bergmann, L, Oosterwijk, E, Kiemeney, LA, Guchelaar, HJ, Jaehde, U
Vydáno v CPT Pharmacometrics Syst Pharmacol (2017)